These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9768373)

  • 41. Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes.
    Marliss EB; Vranic M
    Diabetes; 2002 Feb; 51 Suppl 1():S271-83. PubMed ID: 11815492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiorespiratory fitness predicts insulin action and secretion in healthy individuals.
    Larsen FJ; Anderson M; Ekblom B; Nyström T
    Metabolism; 2012 Jan; 61(1):12-6. PubMed ID: 21700301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of hypoxia and work intensity on insulin resistance in type 2 diabetes.
    Mackenzie R; Elliott B; Maxwell N; Brickley G; Watt P
    J Clin Endocrinol Metab; 2012 Jan; 97(1):155-62. PubMed ID: 21994967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in Type 2 diabetes?
    Staehr P; Hojlund K; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabet Med; 2003 Oct; 20(10):816-22. PubMed ID: 14510862
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.
    Ryan AS; Egan JM; Habener JF; Elahi D
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2399-404. PubMed ID: 9661618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.
    Hirao K; Maeda H; Urata S; Takisawa Y; Hirao S; Sasako T; Sasaki T
    Clin Ther; 2007 May; 29(5):927-934. PubMed ID: 17697911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glucose production, utilization, and cycling in response to moderate exercise in obese subjects with type 2 diabetes and mild hyperglycemia.
    Giacca A; Groenewoud Y; Tsui E; McClean P; Zinman B
    Diabetes; 1998 Nov; 47(11):1763-70. PubMed ID: 9792546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Possible novel index determined by the glucose clamp test for selection of a suitable therapy for each type 2 diabetic patient.
    Gorogawa S; Kaneto H; Matsuhisa M; Ohtoshi K; Kawamori D; Hazama Y; Yoshiuchi K; Yamasaki Y
    Diabetes Res Clin Pract; 2005 Jul; 69(1):1-4. PubMed ID: 15955381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes.
    Bruce CR; Kriketos AD; Cooney GJ; Hawley JA
    Diabetologia; 2004 Jan; 47(1):23-30. PubMed ID: 14673522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness.
    Carey AL; Bruce CR; Sacchetti M; Anderson MJ; Olsen DB; Saltin B; Hawley JA; Febbraio MA
    Diabetologia; 2004 Jun; 47(6):1029-37. PubMed ID: 15168015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucose turnover and its regulation during intense exercise and recovery in normal male subjects.
    Marliss EB; Simantirakis E; Miles PD; Hunt R; Gougeon R; Purdon C; Halter JB; Vranic M
    Clin Invest Med; 1992 Oct; 15(5):406-19. PubMed ID: 1458713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin resistance contributes to carotid arterial wall thickness in patients with non-insulin-dependent-diabetes mellitus.
    Watarai T; Yamasaki Y; Ikeda M; Kubota M; Kodama M; Tsujino T; Kishimoto M; Kawamori R; Hori M
    Endocr J; 1999 Oct; 46(5):629-38. PubMed ID: 10670747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity.
    Mather KJ; Paradisi G; Leaming R; Hook G; Steinberg HO; Fineberg N; Hanley R; Baron AD
    Diabetes Metab Res Rev; 2002; 18(2):118-26. PubMed ID: 11994903
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
    van Haeften TW; Dubbeldam S; Zonderland ML; Erkelens DW
    Diabetes Care; 1998 Feb; 21(2):278-82. PubMed ID: 9539996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of the pharmacodynamic profiles of insulin detemir and insulin glargine: a single dose clamp study in people with type 2 diabetes.
    Luzio SD; Dunseath GJ; Atkinson MD; Owens DR
    Diabetes Metab; 2013 Dec; 39(6):537-42. PubMed ID: 24139704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exercise-Induced Secretion of FGF21 and Follistatin Are Blocked by Pancreatic Clamp and Impaired in Type 2 Diabetes.
    Hansen JS; Pedersen BK; Xu G; Lehmann R; Weigert C; Plomgaard P
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2816-25. PubMed ID: 27163358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.
    Quddusi S; Vahl TP; Hanson K; Prigeon RL; D'Alessio DA
    Diabetes Care; 2003 Mar; 26(3):791-8. PubMed ID: 12610039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dysregulation of muscle glycogen synthase in recovery from exercise in type 2 diabetes.
    Pedersen AJ; Hingst JR; Friedrichsen M; Kristensen JM; Højlund K; Wojtaszewski JF
    Diabetologia; 2015 Jul; 58(7):1569-78. PubMed ID: 25870023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.